The first-generation anatomical medial meniscus prosthesis led to unsatisfactory results: a first-in-human study.

Artificial meniscus Meniscectomy Meniscus prosthesis Meniscus replacement Post-meniscectomy pain syndrome

Journal

Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA
ISSN: 1433-7347
Titre abrégé: Knee Surg Sports Traumatol Arthrosc
Pays: Germany
ID NLM: 9314730

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 06 04 2022
accepted: 17 10 2022
medline: 16 5 2023
pubmed: 7 11 2022
entrez: 6 11 2022
Statut: ppublish

Résumé

The purpose of this first-in-human study was to evaluate the effect of a polycarbonate anatomical meniscus prosthesis system, including the surgical procedure, on knee pain and describe potential adverse events in patients with post-meniscectomy pain syndrome. Eleven patients with post-meniscectomy pain syndrome and limited underlying cartilage damage were enrolled in the study. Five received a medial polycarbonate urethane meniscus prosthesis which was clicked onto 2 titanium screws fixated at the native horn attachments on the tibia. The KOOS score was planned to be collected at baseline and at 3, 6, 12 and 24 months following the intervention including radiographs at 6, 12 and 24 months. MRI scans were repeated after 12 and 24 months. The surgical technique to select an appropriately sized implant and correct positioning of the fixation screws and meniscus prosthesis onto the tibia was demonstrated to be feasible and reproducible. Inclusion stopped after 5 patients because of serious adverse device-related events. All patients reported knee joint stiffness and slight effusion in their knee at 6 months follow-up. In 3 patients the implant was removed because of implant failure and in 1 patient the implant was removed because of persistent pain and extension limitation. In none of the patients did the KOOS score improve in the first 6 months after surgery. However, in the patient who still has the implant in situ, PROMs started to improve 1 year after surgery and this improvement continued through 2 years of follow-up. The KOOS Pain, symptoms and ADL were close to the maximal 100 points. KOOS QoL and sport did improve but remained suboptimal. This first version of the meniscus prosthesis led to impaired knee function and failed in four out of five patients. The patients where the prosthesis was removed were salvable and the PROMs returned to pre-study levels. The results in the patient where the device is still in place are promising. Level II.

Identifiants

pubmed: 36336744
doi: 10.1007/s00167-022-07205-x
pii: 10.1007/s00167-022-07205-x
pmc: PMC10183417
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2526-2533

Informations de copyright

© 2022. The Author(s).

Références

Knee Surg Sports Traumatol Arthrosc. 2020 Nov;28(11):3551-3560
pubmed: 32979080
Knee Surg Sports Traumatol Arthrosc. 2016 May;24(5):1485-94
pubmed: 25971457
Am J Sports Med. 2017 Oct;45(12):2824-2834
pubmed: 28719787
J Exp Orthop. 2022 Sep 7;9(1):91
pubmed: 36071256
J Orthop Surg Res. 2018 Jul 20;13(1):181
pubmed: 30029690
J Knee Surg. 2021 Feb;34(3):303-321
pubmed: 31461756
Am J Sports Med. 2020 Jun;48(7):1696-1701
pubmed: 32396461
Orthop Traumatol Surg Res. 2017 Jun;103(4):609-614
pubmed: 28373139
J Biomech. 2010 Feb 10;43(3):463-8
pubmed: 19896669
Arthroscopy. 2016 Jul;32(7):1337-45
pubmed: 26970835
Health Qual Life Outcomes. 2003 Nov 03;1:64
pubmed: 14613558
Orthop J Sports Med. 2020 Sep 29;8(9):2325967120952414
pubmed: 33062765
Knee Surg Sports Traumatol Arthrosc. 2021 Jun;29(6):1777-1789
pubmed: 32797248
J Mech Behav Biomed Mater. 2014 Jan;29:42-55
pubmed: 24055793
J Biomech. 2015 Jun 1;48(8):1427-35
pubmed: 25766390
J Anat. 2014 Oct;225(4):395-402
pubmed: 25052030
Arthroscopy. 2018 Dec;34(12):3216-3223
pubmed: 30292591
Clin Biomech (Bristol, Avon). 2014 Sep;29(8):898-905
pubmed: 25238685
J ISAKOS. 2022 Apr;7(2):67-77
pubmed: 35543667
Am J Sports Med. 2022 Jan;50(1):128-137
pubmed: 34797194

Auteurs

T G van Tienen (TG)

Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands. tony.vantienen@radboudumc.nl.
ATRO Medical BV, Liessentstraat 9-A, 5405 AH, Uden, The Netherlands. tony.vantienen@radboudumc.nl.

B van Minnen (B)

ATRO Medical BV, Liessentstraat 9-A, 5405 AH, Uden, The Netherlands.

K C Defoort (KC)

Sint Maartenskliniek Nijmegen, Hengstdal 3, 6574 NA, Ubbergen, The Netherlands.

P J Emans (PJ)

Joint-Preserving Clinic, Department of Orthopaedic Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands.

S A W van de Groes (SAW)

Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.

N Verdonschot (N)

Radboud University Medical Centre, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.

L M Jutten (LM)

Joint-Preserving Clinic, Department of Orthopaedic Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands.

R W E Pikaart (RWE)

ATRO Medical BV, Liessentstraat 9-A, 5405 AH, Uden, The Netherlands.

P J C Heesterbeek (PJC)

Sint Maartenskliniek Nijmegen, Hengstdal 3, 6574 NA, Ubbergen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH